DXS International's AGM 2024 Overview
DXS International plc, known under the ticker symbol (AQSE: DXSP), is a prominent player in the healthcare information and digital clinical decision support systems industry. The company recently provided an operational update in advance of its Annual General Meeting (AGM), which fulfilled a vital role in informing stakeholders about the company's progress and future initiatives.
A Glimpse into Recent Developments
The AGM was an opportune moment for the leadership, particularly CEO David Immelman, to highlight significant advancements made by DXS. The company reported robust progress in areas like Aios SMART Referrals and ExpertCare, while also noting a crucial price increase from the National Health Service (NHS).
Aios SMART Referrals: A Breakthrough in Efficiency
One of the standout achievements is the launch of Aios SMART Referrals, enhancing the existing Point of Care solution by introducing a modern cloud-based system. This innovative upgrade involved seamless integration with the NHS Electronic Referral System. Impressively, SMART Referrals are now utilized for 10% of all referrals across England—approximately 1.8 million referrals annually. The integration has impressed NHS authorities, achieving accreditation under the NHS G Cloud 14 Procurement Framework.
Currently, around 22% of the newly formed Integrated Care Boards (ICBs) have practices that have adopted the SMART Referrals system, impacting approximately 6.5 million patients. There remains an exciting opportunity to expand this service to additional GP practices, enabling access to another 6.5 million patients and increasing DXS’s market share.
ExpertCare: Bringing Comprehensive Care Management
ExpertCare represents another significant step forward in DXS's offerings, providing a tailored Long Term Condition therapeutic management solution. The product is progressing well, having completed 75% of its Phase 3 trials supported by Innovate UK and Health Innovate East. York University is conducting an economic impact assessment to gauge the broader implications of this program.
Furthermore, the first commercial sale of ExpertCare was confirmed in a recent announcement, emphasizing the growing recognition and adoption of DXS’s innovative solutions.
Future Strategies and Growth Potential
As DXS International looks to the future, the company is preparing for further expansion into at least one EU territory by 2025. This step reflects their ambition to broaden their market presence and continue delivering high-quality healthcare solutions.
Gratitude Towards Stakeholders
DXS International plc expresses sincere appreciation for the ongoing support from shareholders and stakeholders. This partnership is crucial as the company works to enhance healthcare delivery through innovative technologies and solutions.
Contact Information
For further inquiries, interested parties can reach out to:
David Immelman
DXS International plc
Website: www.dxs-systems.com
Contact: 01252 719800
AQSE Corporate Broker and Corporate Advisor
Hybridan LLP
Contact: Claire Louise Noyce
Phone: 020 3764 2341
Frequently Asked Questions
What is the focus of DXS International plc?
DXS International plc specializes in healthcare information systems and digital clinical decision support, aiming to enhance patient outcomes through innovative solutions.
What recent developments were discussed at the AGM?
The AGM highlighted significant progress in projects like Aios SMART Referrals and ExpertCare, along with a price increase from the NHS.
How does Aios SMART Referrals impact the healthcare system?
Aios SMART Referrals improve referral procedures, currently representing 10% of all referrals in England, effectively streamlining the process for patients and healthcare providers.
What are the future plans for DXS International?
The company aims to expand into at least one European territory by 2025, strengthening its market position while enhancing healthcare delivery.
Who can be contacted for more information about DXS International?
Inquiries can be directed to David Immelman at DXS International plc through their official website or by phone.
